Publications

This page lists the scientific publications related to the EVAg project. The default filter is set to "publications for which the research was funded by the EVAg project". You can change this filter to another value by picking a different filter from the drop-down list and clicking on the "Apply" button.

346 publications displayed

Date Name Journalsort ascending EVAg
Oct 2020 Detection of Usutu virus infection in wild birds in the United Kingdom, 2020 Eurosurveillance Research funded by EVAg, Published by EVAg partner
Jan 2017 Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study The Lancet Global Health Research funded by EVAg, Published by EVAg partner
May 2018 A novel tick-borne phlebovirus, closely related to severe fever with thrombocytopenia syndrome virus and Heartland virus, is a potential pathogen Emerging Microbes & Infections Research funded by EVAg, Published by EVAg partner
Dec 2018 Re-visiting the evolution, dispersal and epidemiology of Zika virus in Asia Emerging Microbes & Infections Research funded by EVAg, Published by EVAg partner
Mar 2018 SuPReMe: a rapid reverse genetics method to generate clonal populations of recombinant RNA viruses Emerging Microbes & Infections Research funded by EVAg, Published by EVAg partner
May 2018 Relationship between circulating vascular endothelial growth factor and its soluble receptor in patients with hemorrhagic fever with renal syndrome Emerging Microbes & Infections Research funded by EVAg, Published by EVAg partner
Jan 2020 Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus Emerging Microbes & Infections Research funded by EVAg, Published by EVAg partner
Jan 2020 Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines Emerging Microbes & Infections Research funded by EVAg, Published by EVAg end-user
Jan 2021 Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort Emerging Microbes & Infections Research funded by EVAg, Published by EVAg end-user
Dec 2018 Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone Emerging Microbes & Infections Research funded by EVAg, Related to EVAg product, Published by EVAg partner
Aug 2016 Differential cell line susceptibility to the emerging Zika virus: implications for disease pathogenesis, non-vector-borne human transmission and animal reservoirs Emerging Microbes & Infections Research funded by EVAg, Published by EVAg partner
Mar 2021 Use of convalescent serum reduces severity of COVID-19 in nonhuman primates Cell Reports Research funded by EVAg, Published by EVAg end-user
Feb 2017 Ultrastructural Characterization of Zika Virus Replication Factories Cell Reports Research funded by EVAg, Published by EVAg partner
Aug 2016 Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype Cell Reports Research funded by EVAg, Published by EVAg partner
Dec 2016 Assay optimization for molecular detection of Zika virus Bulletin of the World Health Organization Research funded by EVAg, Published by EVAg partner
Aug 2016 Background review for diagnostic test development for Zika virus infection Bulletin of the World Health Organization Research funded by EVAg, Published by EVAg partner
Jul 2018 Assessment of vector competence of UK mosquitoes for Usutu virus of African origin Parasites & Vectors Research funded by EVAg, Published by EVAg partner
Dec 2019 Evidence for infection but not transmission of Zika virus by Aedes albopictus (Diptera: Culicidae) from Spain Parasites & Vectors Research funded by EVAg, Related to EVAg product, Published by EVAg partner
Dec 2017 Generic amplification and next generation sequencing reveal Crimean-Congo hemorrhagic fever virus AP92-like strain and distinct tick phleboviruses in Anatolia, Turkey Parasites & Vectors Research funded by EVAg, Published by EVAg partner
Dec 2016 Seroprevalence of Toscana virus in dogs from Corsica, France Parasites & Vectors Research funded by EVAg, Published by EVAg partner
Dec 2017 Tick-borne pathogens induce differential expression of genes promoting cell survival and host resistance in Ixodes ricinus cells Parasites & Vectors Research funded by EVAg, Published by EVAg partner
Dec 2017 Direct evidence for an expanded circulation area of the recently identified Balkan virus (Sandfly fever Naples virus species) in several countries of the Balkan archipelago Parasites & Vectors Research funded by EVAg, Published by EVAg partner
Dec 2017 Serological association between Leishmania infantum and sand fly fever Sicilian (but not Toscana) virus in sheltered dogs from southern Portugal Parasites & Vectors Research funded by EVAg, Published by EVAg partner
Dec 2018 Widespread arenavirus occurrence and seroprevalence in small mammals, Nigeria Parasites & Vectors Research funded by EVAg, Published by EVAg partner
Dec 2017 Sand fly and Leishmania spp. survey in Vojvodina (Serbia): first detection of Leishmania infantum DNA in sand flies and the first record of Phlebotomus (Transphlebotomus) mascittii Grassi, 1908 Parasites & Vectors Research funded by EVAg, Published by EVAg partner
Jul 2016 Phylogenetic analysis of a newfound bat-borne hantavirus supports a laurasiatherian host association for ancestral mammalian hantaviruses Infection, Genetics and Evolution Research funded by EVAg, Published by EVAg partner
May 2016 Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise Cell Research funded by EVAg, Published by EVAg partner
Apr 2021 Extremely potent human monoclonal antibodies from COVID-19 convalescent patients Cell Research funded by EVAg, Published by EVAg end-user
Dec 2020 Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis Nature Communications Research funded by EVAg, Published by EVAg partner
Dec 2021 Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection Nature Communications Research funded by EVAg, Published by EVAg end-user
Feb 2016 Vector-free transmission and persistence of Japanese encephalitis virus in pigs Nature Communications Research funded by EVAg, Published by EVAg partner
Feb 2022 Multilateral benefit-sharing from digital sequence information will support both science and biodiversity conservation Nature Communications Research funded by EVAg, Published by EVAg partner
Dec 2021 Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model Nature Communications Research funded by EVAg, Published by EVAg partner
Dec 2020 A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics Nature Communications Research funded by EVAg, Published by EVAg end-user
Dec 2020 Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients Nature Communications Research funded by EVAg, Published by EVAg partner
Jan 2016 Two clinical cases of renal syndrome caused by Dobrava/Saaremaa hantaviruses imported to the Netherlands from Poland and Belarus, 2012-2014. Infection ecology & epidemiology Research funded by EVAg, Published by EVAg partner
Jan 2019 Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak Science Research funded by EVAg, Published by EVAg partner
Apr 2016 The 3.8 A resolution cryo-EM structure of Zika virus Science Research funded by EVAg, Published by EVAg end-user
Jan 1967 THE ISOLATION OF NEWCASTLE DISEASE VIRUS IN QUEENSLAND Australian veterinary journal Research funded by EVAg, Published by EVAg end-user
Sep 2020 Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates Nature Research funded by EVAg, Published by EVAg partner
Dec 2020 Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis Nature Research funded by EVAg, Published by EVAg partner
Jul 2016 A CRISPR screen defines a signal peptide processing pathway required by flaviviruses Nature Research funded by EVAg, Published by EVAg partner
Jul 2020 A SARS-CoV-2 protein interaction map reveals targets for drug repurposing Nature Research funded by EVAg, Published by EVAg end-user
Oct 2017 Heartland virus NSs protein disrupts host defenses by blocking the TBK1 kinase–IRF3 transcription factor interaction and signaling required for interferon induction Journal of Biological Chemistry Research funded by EVAg, Related to EVAg product, Published by EVAg partner
Aug 2017 A Cluster of Symptomatic and Asymptomatic Infections of Severe Fever with Thrombocytopenia Syndrome Caused by Person-to-Person Transmission The American Journal of Tropical Medicine and Hygiene Research funded by EVAg, Related to EVAg product, Published by EVAg partner
Oct 2019 Rescue of Replication-Competent ZIKV Hidden in Placenta-Derived Mesenchymal Cells Long After the Resolution of the Infection Open Forum Infectious Diseases Research funded by EVAg, Published by EVAg partner
Oct 2020 Virological Characterization of the First 2 COVID-19 Patients Diagnosed in Italy: Phylogenetic Analysis, Virus Shedding Profile From Different Body Sites, and Antibody Response Kinetics Open Forum Infectious Diseases Research funded by EVAg, Published by EVAg partner
Dec 2017 New reverse genetics and transfection methods to rescue arboviruses in mosquito cells Scientific Reports Research funded by EVAg, Published by EVAg partner
Dec 2017 Influenza D in Italy: towards a better understanding of an emerging viral infection in swine Scientific Reports Research funded by EVAg, Published by EVAg end-user
Dec 2019 ZIKV Strains Differentially Affect Survival of Human Fetal Astrocytes versus Neurons and Traffic of ZIKV-Laden Endocytotic Compartments Scientific Reports Research funded by EVAg, Related to EVAg product, Published by EVAg partner

Pages